XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials SUZHOU, China, April 15, 2025 /PRNewswire/ — In January 2025 (U.S. time),… CISION PRNewswireApril 15, 2025
Press ReleaseCIRQUE DU SOLEIL INTRODUCES NEW INTERACTIVE DIGITAL EXPERIENCE, OFFERING BACKSTAGE ACCESS TO FANS Experience the world of KURIOS – Cabinet of Curiosities like never before… CISION PRNewswireApril 15, 2025
Press ReleaseReolink Earth Day 2025: Partnering with NGOs to Drive Global Conservation LOS ANGELES, April 15, 2025 /PRNewswire/ — It starts with a moment… CISION PRNewswireApril 15, 2025
Press ReleaseSECuRE trial update: First patient treated in the Phase II Cohort Expansion HIGHLIGHTS The first of the planned 24 participants in the Cohort Expansion… CISION PRNewswireApril 15, 2025
Press ReleaseGIGABYTE Debuts GeForce RTX™ 5060 Ti & 5060 with Advanced Cooling System for Ultimate Gaming and AI TAIPEI, April 15, 2025 /PRNewswire/ — GIGABYTE, the world’s leading computer brand,… CISION PRNewswireApril 15, 2025
PLAUD.AI Acquires YC-Backed StarJar to Power Its New Enterprise Solution, PLAUD for Business SAN FRANCISCO, April 15, 2025 /PRNewswire/ — PLAUD.AI‘s brand owner PLAUD Inc.,… CISION PRNewswireApril 15, 2025
Acer Debuts Nitro Gaming PCs Featuring Latest NVIDIA GeForce RTX 50 Series GPUs New Acer Nitro AI laptops with slim options and the Nitro 20… CISION PRNewswireApril 15, 2025
Thales to Offer Prime Factors' Bank Card Security System Prime Factors and Thales Extend Collaboration to Help Customers Build More Secure… CISION PRNewswireApril 15, 2025
